Active ingredients:

Ceftriaxone as sterile ceftriaxone sodium - 500 mg or 1000 mg or 2 g.

CEFTRIAXONE-BCPP is a 3rd generation cephalosporin antibiotic for intramuscular or intravenous administration. The preparation is indicated for the treatment of stains resistant to other cephalosporins, aminoglycosides, penicillins, etc.

Indications

Infectious-inflammatory diseases caused by microorganisms sensitive to the medicinal product:

• respiratory tract infections, particularly pneumonia, as well as ear, throat and nose infections;
• abdominal cavity organs infections (peritonitis, urinary tract and gastrointestinal tract infections);
• renal and urinary infections;
• genital infections, including gonorrhea;
• sepsis;
• infections of bones, joints, soft tissues, skin and wound infections;
• infections in patients with weakened immune system;
• meningitis;
• disseminated Lyme disease (II and III stages);
• perioperative prevention of infections during surgery on the organs of the gastrointestinal tract, biliary tract, urinary tract and during gynecological procedures, but only in cases of known or potential contamination.

Dosage and pharmaceutical form:

Powder for solution for injection of 500 mg. 1 vial with powder; 1 vial in carton; 1 vial with powder together with solvent (water for injection) in 5 ml ampoule in carton with cardboard divider.

Powder for solution for injection of 1000 mg. 1 vial with powder; 1 vial in carton; 1 vial with powder together with solvent (water for injection) in 5 ml or 10 ml ampoule in carton with cardboard divider; 1 vial with powder together with solvent (lidocaine hydrochloride, solution for injection, 10 mg/ml) in 3.5 ml ampoule in carton with cardboard divider.

Powder for solution for injection of 2 g. 1 vial with powder; 1 vial in carton.